// App-Quantinova.ai

1134 : The Cost Analysis Of Aspirin Versus Low Molecular Weight Heparin For Thromboprophylaxis Following Total Hip Arthroplasty

Researchers

Presenter

  • Owen Chauhan

Principal Investigators

  • Chris Skedgel

  • Susan Pleasance

  • Kara Thompson

  • David Anderson

Medical Centers

  • Capital Distric Health Authority, Halifax, NS, Canada

  • Dalhousie University, Faculty of Medicine, Halifax, NS, Canada

  • Research Methods Unit, Dalhousie University, Halifax, NS, Canada

  • Dalhousie University, Halifax, Nova Scotia, Canada.

  • Atlantic Clinical Cancer Research Unit, Halifax, NS, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

  • Deep vein thrombosis

  • Pulmonary embolism

Biomarkers

  • N/A

Drug/Treatment

  • dalteparin Subcutaneous

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved